• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Life Sciences British Columbia

  • Members Area |
  • Contact Us
  • SearchSearch
  • About
    • Board of Directors
    • Management
    • Vision & Mission
    • LSBC Hall of Fame
  • Awards
  • Membership
    • Sponsors
    • Members Directory
    • Members Area
    • Membership Benefits
    • Membership Discounts
    • Members Services
    • Members Map
    • Become a Member
  • Events
    • Calendar
    • Webinars
    • Past Events
      • 2023 Events
      • 2022 Events
      • 2021 Events
      • 2020 Events
      • 2019 Events
      • 2018 Events
  • News
    • All News
    • Member News
    • Industry News
    • LSBC in The News
    • Publications
    • BC Labour Market Study
  • Resources
    • All Resources
    • Grants and Funding
      • Funding Competitions
      • Wage Subsidies
    • Academic Institutions
    • Government
      • Federal
      • Provincial and Municipal
    • Association Partners
    • Programs
    • Volunteering
  • Jobs
    • Job Board
    • Post a Job
    • Career Events
  • Contact Us
  • Login
Home » News » All News

All News

  • Member News
  • Industry News
  • LSBC in The News
Member News

NervGen Pharma Reports 2022 Year End Results and Provides Operational Update Including Plans to Initiate Phase 1b/2a Clinical Trial of Proprietary NVG-291 in Q3 2023

March 30, 2023 – NervGen Pharma Corp.

Equity proceeds of CA$22M+ raised during 2022 fiscal year Phase 1 clinical trial dosing of proprietary compound, NVG-291, is complete and data analysis is ongoing Phase 1b/2a clinical trial of… Read More

Member News

2023 Canada Gairdner Awards Recognize World-Renowned Scientists for Transformative Contributions to Research Impacting Human Health

March 30, 2023 – Gairdner Foundation

TORONTO, ON — The Gairdner Foundation is pleased to announce the 2023 Canada Gairdner Award laureates, recognizing some of the world’s most significant biomedical and global health research and discoveries…. Read More

Member News

Gandeeva and Moderna Enter into Cryo-EM Research Collaboration to Explore Protein Surface Structure at Atomic Resolution

March 30, 2023 – Gandeeva Therapeutics

VANCOUVER, BC – Gandeeva Therapeutics, Inc., a precision medicine company focused on designing and developing novel therapeutics guided by cryogenic electron microscopy (cryo-EM) and machine learning, announced today the initiation… Read More

Member News

Sustained Therapeutics Announces Second Phase II Trial of New Drug Platform

March 30, 2023 – Sustained Therapeutics

VANCOUVER, BC — A Vancouver-based therapeutics company has begun a second Phase II trial of its novel long lasting non-opioid pain medication, with a specific focus on treating Chronic Scrotal… Read More

Member News

Notch Therapeutics Promotes Chris Bond to Chief Scientific Officer

March 29, 2023 – Notch Therapeutics Comms

VANCOUVER, BC — Notch Therapeutics, Inc., a biotechnology company developing renewable, induced pluripotent stem cell (iPSC)-derived cell therapies for cancer, is pleased to announce Dr. Chris Bond has been promoted to… Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 331
  • →

Primary Sidebar

  • Category:

  • Sector:

  • Archives:

© 2023 Life Sciences BC  |  Privacy Policy

  • Current Jobs
  • Event Calendar
  • All News
  • Member Directory
    Connect with us
  • LinkedIn
  • Twitter
  • Facebook
  • Instagram
Contact Us